@recursionpharma Avatar @recursionpharma Recursion

Recursion posts on YouTube about ai, gibson, ceo, #ai the most. They currently have [-------] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-------] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 17.82% technology brands 11.88% finance 7.92% countries 4.95% exchanges 3.96% pga golfers 3.96% social networks 3.96% financial services #2180 travel destinations 2.97%

Social topic influence ai 31.68%, gibson #952, ceo 13.86%, #ai 10.89%, in the 6.93%, data 6.93%, the first 6.93%, mit 6.93%, state of 4.95%, up to 3.96%

Top accounts mentioned or mentioned by @najat @valencelabs @mit @nvidia @livicusinvest

Top assets mentioned Jazz Pharmaceuticals, Inc. (JAZZ) Tempus AI, Inc. (TEM) Goldman Sachs (GS) Recursion Pharmaceuticals, Inc. (RXRX) Sanofi (SNY) Beam Therapeutics, Inc. (BEAM)

Top Social Posts

Top posts by engagements in the last [--] hours

"NVIDIA CEO: [--] Signs Tech Shift Is Happening in Pharma At Download Day NVIDIA CEO Jensen Huang talks to Recursion co-founder and CEO Chris Gibson about the parallels he sees between his industry and the rise of advanced computing and the current technological shift happening in pharma thanks to Recursions Operating System know-how and computing ability. He says: These three things are in play: 1) The invention of a new algorithm a new family of algorithms that we call deep learning; 2) Supercomputing capabilities that youve used here and that weve partnered with you to create; 3) And of course"
YouTube Link 2024-07-17T13:37Z 105K followers, [----] engagements

"Recursion 101: The Industrial Revolution of Drug Discovery Is Here Recursion (NASDAQ: RXRX) is a leading clinical-stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS) a platform built across diverse technologies that continuously expands one of the worlds largest proprietary biological chemical and patient-centric datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by"
YouTube Link 2026-01-08T14:53Z 105K followers, 148.6K engagements

"Recursion's Q4 / FY [----] (L)earnings Call Join us for our Q4/FY [----] (L)earnings Call"
YouTube Link 2026-02-16T22:10Z 106K followers, [--] engagements

"TechBio Talks: Katie Couric and Najat Khan Recursion CEO and President Najat Khan talks to award-winning journalist filmmaker podcaster and co-founder of Stand Up to Cancer Katie Couric about their personal motivations; the current state of AI drug discovery; and exciting proof points like Recursions potential first-in-disease treatment for the rare disease familial adenomatous polyposis (FAP)"
YouTube Link 2026-02-11T11:53Z 106K followers, [---] engagements

"Fireside Chat: Recursion CEO and President Najat Khan PhD and Katie Couric at JPM [----] At Recursion's event at the [----] J.P. Morgan Healthcare Conference Katie Couric award-winning journalist filmmaker podcaster and co-founder of Stand Up to Cancer interviewed Recursion CEO and President Najat Khan about her vision for the company the latest positive clinical results from Recursion's REC-4881 AI-identified drug for patients with FAP and how investors and partners can separate hype from real AI breakthroughs"
YouTube Link 2026-01-22T03:38Z 105K followers, [---] engagements

"TechBio Talks Panel with Katie Couric Renee Gala Reid Hoffman Eric Topol and Eric Lefkofsky At Recursion's event at the [----] J.P. Morgan Healthcare Conference award-winning journalist filmmaker podcaster and co-founder of Stand Up to Cancer Katie Couric moderated a discussion with Renee Gala of Jazz Pharmaceuticals; Reid Hoffman of Manas AI; Eric Topol of Scripps Research Institute; and Eric Lefkofsky of Tempus AI on the best places to deploy capital to drive AI innovation in healthcare; how to distinguish clinical impact from AI hype; and how AI-driven drug discovery is positioned to impact"
YouTube Link 2026-01-22T13:53Z 106K followers, [----] engagements

"Fireside Chat: Recursion CEO Chris Gibson & Nvidia's Jensen Huang at Recursion's Download Day NVIDIA Founder & CEO Jensen Huang sits down with Recursion Co-founder & CEO Chris Gibson for a Fireside Chat at Download Day [----]. About Recursion: Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS) a platform built across diverse technologies that continuously expands one of the worlds largest proprietary biological chemical and patient-centric datasets. Recursion leverages"
YouTube Link 2024-06-28T12:20Z 105K followers, 42.5K engagements

"REC-4881 in FAP: Data Update Webinar On December [--] [----] Recursion announced positive Phase 1b/2 data from the ongoing TUPELO trial of REC-4881 an investigational allosteric MEK1/2 inhibitor for familial adenomatous polyposis (FAP). In the Phase [--] portion of the study REC-4881 demonstrated rapid and durable reductions in polyp burden with 43% median reduction in evaluable patients after [--] weeks of treatment. 75% of evaluable patients had a reduction in polyp burden in this same period. Importantly the effect persisted well beyond the dosing period: 82% of evaluable patients (9 of 11)"
YouTube Link 2025-12-08T13:01Z 105K followers, [----] engagements

"Highlights from Recursion's TechBio Talks Live Event at the [----] J.P. Morgan Healthcare Conference Recursion hosted a packed TechBio Talks Live event at the San Francisco Mint during the [----] J.P. Morgan Healthcare Conference with an introduction from CEO and President Najat Khan PhD and a fireside chat with Najat and award-winning journalist filmmaker podcaster and co-founder of Stand Up to Cancer Katie Couric. Katie moderated a panel discussion on the future of AI in healthcare and medicine featuring: Renee Gala President and CEO of Jazz Pharmaceuticals Reid Hoffman Co-founder LinkedIn"
YouTube Link 2026-01-22T14:33Z 105K followers, 51.2K engagements

"Recursion CFO Ben Taylor Discusses Platform Pipeline & Driving Value from Boltz-2 at Goldman Sachs Last week Recursion CFO Ben Taylor spoke with Salveen Richter biotech analyst at Goldman Sachs at the Goldman Sachs 46th Annual Healthcare Conference in Miami. They discussed validation points for the Recursion Operating System pipeline advances and how we drive value from collaborations like Boltz-2. ✨ A few highlights: 🔹 In what ways has your platform achieved proof of concept Weve had a number of different points of validation. On the chemistry side weve had a number of compounds in-licensed"
YouTube Link 2025-06-17T15:00Z 105K followers, [----] engagements

"Recursion's Najat Khan PhD at Fierce JPM Panel Discussing "Our AI Future" For a TechBio company to have so many programs it has to be powered by something that's different from how we do things today. In a panel discussion on Our AI Future from Fierce at the J.P. Morgan Healthcare Conference Chief R&D and Chief Commercial Officer Najat Khan PhD described how Recursion is leveraging our multi-omic data stack to train AI models and unlock biological insights. Were building a state-of-the-art data stack with Genetics transcriptomics proteomics phenomics patient and real world data she said not"
YouTube Link 2025-01-31T20:20Z 105K followers, [----] engagements

"RxRx1: Machine Learning Dataset for Drug Discovery Recursion Pharmaceuticals opens a glimpse of its massive biological images dataset for the machine learning community to develop new algorithms that will inevitably improve drug development"
YouTube Link 2019-06-27T21:21Z 89.9K followers, [----] engagements

"Chris Gibson & Dave Hallett on Recursion-Exscientia Definitive Agreement Chris Gibson and Dave Hallett discuss their shared vision for industry-shifting tech-enabled drug discovery and how their complementary platforms and approaches can accelerate the discovery of better drugs for patients. Learn more and review important and required disclosure related to this information here: https://www.globenewswire.com/news-release/2024/08/08/2926843/0/en/Recursion-and-Exscientia-Enter-Definitive-Agreement-to-Create-a-Global-Technology-Enabled-Drug-Discovery-Leader-with-End-to-End-Capabilities.html #ai"
YouTube Link 2024-08-12T14:52Z 106K followers, [----] engagements

"How Recursion Used AI to Find a Novel Way to Potentially Treat a Debilitating Rare Disease A new video shares the story of Recursions investigational drug REC-4881 for the rare disease familial adenomatous polyposis (FAP) which affects more than [-----] people in the US and EU5 and has no approved medicines. Patients with this disease develop hundreds to thousands of polyps in their early teens to 20s that if left untreated have a nearly 100% risk of developing into colon cancer. Heres how we did it: Using the Recursion OS platform to analyze cell morphology we tested thousands of compounds to"
YouTube Link 2026-02-03T14:18Z 106K followers, [----] engagements

"Act Boldly With Integrity -- CEO Chris Gibson on the Recursion Mindset In a recent video for our internal Recursion University (RXU) series co-founder and CEO Chris Gibson illustrates the importance of one of our core values act boldly with integrity. Launched in [----] RXU is a platform for both new and tenured Recursionauts to dive deep into what makes us tick including our mindset mission and value drivers learning directly from company leaders. In this installment Chris illustrates a key difference in how we make decisions: optimizing for world-changing impact over incremental progress. We"
YouTube Link 2025-07-22T13:45Z 106K followers, [----] engagements

"Inside the Recursion-Exscientia definitive agreement Chris Gibson and Dave Hallett discuss their shared vision for industry-shifting tech-enabled drug discovery and how their complementary platforms and approaches can accelerate the discovery of better drugs for patients. Learn more and review important and required disclosure related to this information here: https://www.globenewswire.com/news-release/2024/08/08/2926843/0/en/Recursion-and-Exscientia-Enter-Definitive-Agreement-to-Create-a-Global-Technology-Enabled-Drug-Discovery-Leader-with-End-to-End-Capabilities.html #ai #techbio #tech"
YouTube Link 2024-08-12T14:50Z 89.9K followers, [----] engagements

"One Thing I Wish My Family Understood About My Work at Recursion In a new video Communications and Culture Fellow Katherine Matsumoto asks Recursionauts: What is one thing you wish your families understood about the work that you do For many its all about the patients. #onething #Recursionaut #culture #TechBio #drugdiscovery"
YouTube Link 2025-11-18T19:18Z 106K followers, [----] engagements

"Driving Better Predictions: Recursion CFO Ben Taylor at the Citi Biopharma Back to School Summit 🔹 Highlights: 💡 On bringing novel technology to partnerships. "We leverage our phenotypic platform to understand biology in new ways. We dont use our data as a service - but we use it to define better targets design better drugs and find better patient populations for partners." 💡 On the rise of new #techbio startups. "Designing an algorithm is not the hardest part. You need to create a system that has thousands of integrated models. You need to know each one of those models is independently"
YouTube Link 2025-09-09T14:07Z 106K followers, [----] engagements

"From World Model to Virtual Cell: Recursion CEO Chris Gibson at Recursion's JPM Era of TechBio Event Closing remarks from Recursion cofounder and CEO Chris Gibson at Recursion's Era of TechBio event at the San Francisco Mint during the [----] J.P. Morgan Healthcare Conference. Chris closed the night by talking about how Recursion is building a true combination of wet lab and dry lab that is paving the way for the first true virtual cell. "What we've believed for the last [--] years at Recursion is that what you have to do is build datasets" he said. "Those datasets have to be really really high"
YouTube Link 2025-02-12T14:47Z 98K followers, [----] engagements

"Recursion's Q3 [----] (L)earnings Call Join us for our Q3 [----] (L)earnings Call"
YouTube Link 2025-11-05T12:59Z 106K followers, [----] engagements

"Recursion's (L)earnings Call 1Q [----] May [--] [----] Join us live at 6:00am MT / 8:00am ET / 1:00pm BST Highlights: Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease while deprioritizing [--] clinical programs and [--] preclinical program following a strategic data-driven review Partnerships: Achieved fourth milestone in Sanofi collaboration generating $7 million for an orally active small-molecule lead with best-in-class potential in autoimmune diseases Platform and Operations:"
YouTube Link 2025-05-05T12:55Z 95.5K followers, [----] engagements

"Recursion Operating System (OS) Finds Undruggable Targets Were not interested in what we already know were interested in whats novel. Through the power of our platform: Recursion OS we are able to identify undrugged targets. With one of the largest biological and chemical datasets coupled with the ability to rapidly layer on scientific literature using LLMs we are now automatically initiating new discovery programs at scale. See how we use a data driven approach to identify impactful and untapped drug targets using our Recursion OS"
YouTube Link 2024-04-02T16:38Z 105K followers, [----] engagements

"Chris Gibson Presents "State of Recursion" at Download Day [----] Recursion's Co-founder & CEO Chris Gibson PhD presents "State of Recursion" at Download Day [----]. About Recursion: Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS) a platform built across diverse technologies that continuously expands one of the worlds largest proprietary biological chemical and patient-centric datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a"
YouTube Link 2024-06-28T12:22Z 105K followers, [----] engagements

"Recursionauts Series: Dean Li M.D Ph.D We believe that our unique approach to drug discovery at the convergence of biology computation ai & ML will set us apart as the leader of techbio. Hear how tech applications are shifting the industry from Recursion Co-founder & President of Merck Research Labs Dean Li. About Recursion: Recursion is a clinical-stage biotechnology company that aims to decode biology to radically improve lives. Recursion is harnessing the convergence of multiple breakthrough technologies that allow scientists to explore uncharted areas of biology and unravel its complexity"
YouTube Link 2023-05-01T15:17Z 105K followers, [---] engagements

"Recursionauts Series: Terry-Ann Burrell MBA Meet Terry-Ann Burrell MBA Chief Financial Officer of Beam Therapeutics & Recursion Board Member. In the latest episode of our Recursionauts series Terry-Ann highlights how our AI-based technology can decrease the failure rate in drug discovery and make healthcare more affordable - helping us radically improve peoples lives. About Recursion: Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS a platform built across diverse technologies that"
YouTube Link 2023-09-13T14:06Z 105K followers, [---] engagements

"Working @ Recursion Recursion AI Machine Learning Recursion AI Machine Learning"
YouTube Link 2019-07-30T21:43Z 105K followers, [----] engagements

"Inside the the Most Powerful Supercompuer in Pharma Drug discovery is now a technology industry. It used to be that supercomputers were only found in aerospace and engineering. Now together with NVIDIA Recursion has built one of the top [--] supercomputers in the world BioHive-2 to digitize biological data at a resolution and scale that can rapidly accelerate new discoveries and new medicines. Although demand for GPUs and supercomputers has been extremely high were moving at Recursion speed. Together we built BioHive-2 in less than three weeks. Learn more:"
YouTube Link 2024-07-09T13:42Z 105K followers, [----] engagements

"New Open Source Model from MIT & Recursion Solves Major Hurdle in AI Drug Discovery Boltz-2 is a new open source AI model from MIT and Recursion capable of predicting protein binding affinity with unprecedented speed scale and accuracy. Boltz-2 is the first model to combine structure and binding affinity prediction approaching the accuracy of physics-based free energy perturbation (FEP) calculations while being over [----] times faster and less computationally expensive. 💥 The model addresses a critical bottleneck in small molecule drug discovery. A powerful tool built on novel machine"
YouTube Link 2025-06-06T15:32Z 105K followers, [----] engagements

"2024 NVIDIA GTC Tour Have a look at the first moments of GTC - our Chief Comms Officer does a fun walk through and ends up at the Recursion booth for the Phenom-Beta and LOWE demos"
YouTube Link 2024-03-20T15:26Z 105K followers, [----] engagements

"Rare Disease Day [----] at Recursion HQ Have a look at our Rare Disease Day Event at Recursion HQ in Salt Lake City"
YouTube Link 2024-03-20T15:20Z 105K followers, [---] engagements

"2022 Recursion J.P. Morgan Healthcare Presentation #JPMH22 Watch Co-Founder & CEO Chris Gibson PhD present at the [----] J.P. Morgan Healthcare conference on our milestones and whats next as we continue to decode biology to radically improve lives. #JPMHC22"
YouTube Link 2022-01-13T18:01Z 106K followers, [----] engagements

"Recursion's Mapping & Navigating Demonstration Our first-ever public Map demonstration dives into our process and software for navigating complex biological and chemical relationships to uncover potential new treatments for patients. Join Founding Fellow Mason Victors for a step-by-step tutorial. ----------------------------------- About Recursion Recursion is the clinical-stage biotechnology company industrializing drug discovery by decoding biology. Enabling its mission is the RecursionOS a platform built across diverse technologies that continuously expands one of the world's largest"
YouTube Link 2022-12-20T00:40Z 105K followers, [----] engagements

"Royal Society Conference [----] Recursion VP of Data Science Imran Haque Recursion's Vice President of #DataScience Imran Haque Ph.D. presented at the [----] #RoyalSociety Conference watch to learn how were industrializing cellular imaging to decode #biology using artificial intelligence and machine learning. About Recursion: Recursion is a clinical-stage biotechnology company that aims to decode biology to radically improve lives. Recursion is harnessing the convergence of multiple breakthrough technologies that allow scientists to explore uncharted areas of biology and unravel its complexity to"
YouTube Link 2023-06-20T20:45Z [----] followers, [---] engagements

"CDK7 Interim Data Update Call"
YouTube Link 2024-12-10T14:15Z [----] followers, [---] engagements

"Recursion's L(earnings) Call"
YouTube Link 2024-08-08T13:15Z [----] followers, [----] engagements

"Using Imaging Data for AI Drug Discovery Imran Haque SVP of AI and Digital Sciences at Recursion walks us through the treasure trove of data found in images explaining how we use algorithms to structure pixels how we are leading discovery in the field and the massive advances that have been made in training foundation models to make new predictions of promising therapeutic targets. Some highlights: Imaging and algorithms can provide as much or more information than RNA sequencing and cost far less money so you can run more experiments and you dont have to kill the cells to do it. With ML"
YouTube Link 2024-09-06T14:53Z [----] followers, [----] engagements

"Jennifer Doudna at Recursion's JPM Event: Leveraging CRISPR to Generate Data for AI At Recursions Era of TechBio event at the J.P. Morgan Healthcare Conference Natasha Loder health editor of The Economist spoke to Nobel Prize winner in Chemistry Jennifer Doudna founder of the Innovative Genomics Institute who has pioneered work in CRISPR gene editing in a Keynote discussion. 👉 Watch the full Keynote here: https://www.youtube.com/watchv=Eip9DNUkP4o #CRISPR #AI #ML #JPM25 #TechBio"
YouTube Link 2025-02-14T18:40Z [----] followers, [----] engagements

"Highlights from the [----] Molecular Machine Learning Conference We had a great turnout for the [----] Molecular Machine Learning Conference (#MoML) at Mila - Quebec Artificial Intelligence Institute. Sponsored by Recursion and Valence Labs along with Genesis Therapeutics and Braidwell the annual event convenes researchers from academia and industry to discuss how ML methods can address key scientific goals related to molecular modeling molecular interactions and therapeutic design. 💡 Key topics at MoML [----] included: ML for quantum chemistry molecule/protein 3D structure prediction modeling"
YouTube Link 2025-06-24T13:30Z 106K followers, [---] engagements

"LOWE: An LLM-Orchestrated Workflow Engine for Drug Discovery LOWEour LLM-Orchestrated Workflow Engineis an LLM agent that represents the next evolution of the Recursion OS. LOWE supports drug discovery programs by orchestrating complex workflows. These workflows chain together a variety of steps and tools from finding significant relationships within Recursions Maps of Biology and Chemistry to generating novel compounds and scheduling them for synthesis and experimentation. Through its natural language interface and interactive graphics LOWE puts state-of-the-art AI tools into the hands of"
YouTube Link 2024-01-08T15:48Z [----] followers, [----] engagements

"Advancing full-stack AI solutions to deliver better drugs Last month Sid Jain SVP of Clinical Development and Data Science at Recursion discussed how Recursion is applying AI and technology to accelerate the discovery and development of new medicines in a webinar with Drug Discovery World. 💡 He discussed: 🔹 How we moved from point solutions to a full stack overhaul of drug discovery and development. 🔹 How our end-to-end platform translates to better drugs. 🔹 How we are using AI to improve clinical development -- identifying patients who are more likely to respond to treatment and"
YouTube Link 2025-07-14T13:25Z 106K followers, [---] engagements

"Decoding Biology with Data Abundance Recursion's Imran Haque SVP of AI and Digital Sciences Imran Haque SVP of AI and Digital Sciences at Recursion joined researchers at the Broad Institute's [----] Machine Learning in Drug Discovery Symposium to share how Recursion is leveraging petabyte-scale proprietary data to map biology and chemistry and industrialize drug discovery. Watch the full presentation to explore how we are turning drug discovery into a search problem and revolutionizing the field with a technology-forward approach. To learn more about our technology visit"
YouTube Link 2023-12-04T15:39Z [----] followers, [----] engagements

"Download Day [----] State of Drug Discovery & State of Recursion by Chris Gibson Co-founder & CEO Recursion's Co-founder & CEO Chris Gibson PhD presents "State of Drug Discovery & State of Recursion" at Download Day [----]. About Recursion: Recursion is a clinical-stage biotechnology company that aims to decode biology to radically improve lives. Recursion is harnessing the convergence of multiple breakthrough technologies that allow scientists to explore uncharted areas of biology and unravel its complexity to navigate the path to better treatments. The company has built a massive proprietary"
YouTube Link 2023-02-09T19:29Z [----] followers, [----] engagements

"Celebrating Recursion's 10th Anniversary Here's to a decade Check out some of the best moments from our 10-year anniversary celebration. From humble beginnings to #groundbreaking achievements this journey has been nothing short of incredible. A heartfelt thank you to our dedicated team of #Recursionauts and everyone who has supported us along the way. The best part We're just getting started"
YouTube Link 2023-11-20T22:03Z [----] followers, [---] engagements

"Live from NeurIPS: Faster More Accurate Generation of Molecular Properties with ET-Flow At NeurIPS Majdi Hassan from @valence_labs powered by Recursion explains ET-Flow - Equivariant Transformer Flow-Matching for Molecular Conformer Generation which uses a generative technique called flow matching to quickly generate lots of molecular poses or conformations in order to more accurately represent molecules. The ET-Flow method is parameter efficient generating conformations in as little as five steps Majdi explains making it great for high throughput applications. And the molecules are really"
YouTube Link 2024-12-13T17:21Z [----] followers, [---] engagements

"Recursion's Chris Gibson on Building a Virtual Cell to Supercharge Drug Discovery During the recent Q2 [----] (L)earnings Call Recursion cofounder and CEO Chris Gibson shared how Recursion is approaching a virtual cell -- with multiple layers from protein to atomistic and agentic AI"
YouTube Link 2025-08-06T14:15Z 106K followers, [---] engagements

"Why Big Pharma Is Increasingly Working with TechBio Partners: Najat Khan PhD at Barclay's Recursion Chief R&D Officer and Chief Commercial Officer Najat Khan PhD speaks with Peter Lawson a biotech analyst at Barclays and discusses why Big Pharma is increasingly working with TechBio partners. Najat: I think every pharma company is looking at what are the two three areas that are the most challenging to develop a drug whether it's novel biology instead of going after more me too targets; whether it's designing molecules especially lead optimization which is quite challenging in small molecules;"
YouTube Link 2025-06-25T14:41Z 106K followers, [----] engagements

"TechBio Talks Episode [--] Teaser: MIT's Regina Barzilay with Host Najat Khan A sneak peek at the first episode of TechBio Talks -- host Najat Khan sits down with MIT Distinguished Professor & leading AI researcher Regina Barzilay for a fascinating conversation about the new AI technologies that are transforming healthcare"
YouTube Link 2025-09-02T11:16Z 106K followers, [----] engagements

"Advancing AI Cancer Drug REC-1245 to Clinical Trials REC-1245 Recursions first program to reach clinical studies that derived from our AI-enabled Maps of Biology -- has received FDA IND clearance for a Phase I/2 clinical trial progressing from target identification to IND enabling studies in under [--] months. REC-1245 is a potentially first-in-class potent and selective RBM39 degrader for the treatment of biomarker enriched solid tumors and lymphoma. Preclinical data supports that RBM39 degradation induces splicing defects which downregulate DNA Damage Response (DDR) networks and cell cycle"
YouTube Link 2024-10-02T12:00Z [----] followers, [----] engagements

"Maureen Makes VP of Engineering at Recursion at London Code to Cure Event Maureen Makes VP of Engineering and the site lead for Recursions London office recently shared insights as part of Code to Cure: The London TechBio Revolution co-hosted by Relation and British Land. Alongside panelists Sergei Yakneen CTO of Isomorphic Labs; Lindsay Edwards CTO of Relation; Luke Timmerman Founder of Timmerman Reports; and Nerida Scott Head of Innovation at Johnson & Johnson Maureen shared Recursions approach to automating novel discovery and rapidly generating new molecules. We're generating these huge"
YouTube Link 2025-03-06T14:39Z [----] followers, [---] engagements

"CCM Patient Conference [----] - Keynote Speech by Recursion CEO & Co-founder Chris Gibson To kick off the [----] CCM Patient Conference in Miami on July [--] [----] Chris Gibson our co-founder and CEO gave a heartfelt and engaging keynote speech on our efforts to discover and develop potential CCM treatments and industrialize drug discovery. To learn more about the Alliance to Cure Cavernous Malformation go to http://www.AllianceToCure.org/. About Recursion: Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the"
YouTube Link 2023-08-10T14:24Z [----] followers, [----] engagements

"Fireside Chat w/ Nobel Winner in Chemistry & CRISPR Pioneer Jennifer Doudna at Recursion's JPM Event Natasha Loder health editor of The Economist speaks to Nobel Prize winner in Chemistry Jennifer Doudna -- a biochemist who has pioneered work in CRISPR gene editing -- in a Fireside Chat at Recursion's Era of TechBio event at the J.P. Morgan Healthcare Conference. In the discussion Doudna described how she sees incredible promise ahead with tech advancing quickly and the increasing convergence of technologies from delivering molecules to cells in vivo to using AI to guide gene editing"
YouTube Link 2025-02-12T13:58Z [----] followers, [---] engagements

"TechBio Talks Episode [--] Teaser: Broad Institute's Anne Carpenter with Host Chris Gibson A sneak peek of the candid conversation between host Chris Gibson cofounder and CEO of Recursion and Anne Carpenter Institute Scientist and Imaging Platform Senior Director at the Broad Institute of MIT & Harvard where they reflect on their pre-Recursion history and how they formed a lifelong partnership that would help chart the course for the TechBio industry. Full episode drops on Oct. [--] [----] 🎙 Subscribe to TechBio Talks now on: Spotify: https://open.spotify.com/show/2bjoBPssiZVmjYKG4AlaW4 YouTube:"
YouTube Link 2025-09-30T13:31Z 106K followers, [---] engagements

"The Benefits of an AI-Led Approach to Drug Discovery Are Already Being Felt At the J.P. Morgan 53rd Annual Global Technology Media and Communications Conference Recursion CFO Ben Taylor and Lina Nilsson SVP Head of Platform spoke with Ethan Taylor VP in J.P. Morgan's Healthcare Investment Banking Group. They discussed tangible progress in AI drug discovery the evolution of Recursions platform and how were delivering for pharma partners. 👉 Listen to the full conversation here:"
YouTube Link 2025-05-20T13:25Z [----] followers, [----] engagements

"Announcing the First Winner of the Chris and Summer Gibson Founder Fellowship: Elnora AI Carmen Kivisild PhD founder and CEO of Elnora AI is the first winner of the Chris and Summer Gibson Founder Fellowship a new program which provides early-career scientists with up to $150000 in funding scientific support and mentorship to accelerate the growth of their startups at the Recursion-supported Altitude Lab in Salt Lake City. Why Elnora AI Founded by Estonia native Kivisild Elnora is building an AI-powered lab protocol optimizer that captures real-world experimental data directly from academic"
YouTube Link 2025-02-18T20:15Z [----] followers, [---] engagements

"Broadening the Impact - Maureen Makes Director of Engineering at Recursion In a data-driven drug-discovery company engineering is the bridge that connects different functions and locations. It's a position that allows an engineer to create an out-sized impact towards a mission of revolutionizing drug discovery. Learn more about Recursion's bold data-enabled drug discovery - https://www.recursion.com See open roles at: https://www.recursion.com/careers"
YouTube Link 2022-03-25T17:30Z [----] followers, [---] engagements

"Is AI Drug Discovery Is in Its Chip Industry Era Recursion cofounder and CEO Chris Gibson sat down with David Bearss cofounder and CEO of Halia Therapeutics and host of the Good Medicine Podcast to discuss the pitch that launched Recursion the rapid acceleration of #TechBio and why he still believes that a massive sea change in how medicines are made is coming soon. 👉 Check out the full conversation: https://www.youtube.com/watchv=0LaOJkHYVGk"
YouTube Link 2025-06-20T14:22Z 106K followers, [----] engagements

"Recursion Celebrates Opening of New Canadian Headquarters in Toronto On June [--] [----] government officials and leaders from across the biotech ecosystem joined Recursion to celebrate the opening of its [-----] square foot Toronto site which will serve as the headquarters for Recursion Canada. As the company's largest site outside of its global headquarters in Salt Lake City Utah the new site represents Recursions significant growth in Canada and its continued investment in the local economy. About Recursion: Recursion is a clinical stage TechBio company leading the space by decoding biology to"
YouTube Link 2023-07-21T14:09Z [----] followers, [---] engagements

"November [--] Update Call"
YouTube Link 2024-11-20T13:08Z [----] followers, [----] engagements

"One Thing I Learned at Recursion's TechBio Symposium We love learning from one another at Recursion. At our recent TechBio Symposium Recursionauts from around the world gathered in Salt Lake City for a two-day jam-packed series of talks on every aspect of our technology and approach. Resident Communications and Culture Fellow Katherine Matsumoto finds out which presentations left an impression. #onething #OneRecursion #techbio"
YouTube Link 2025-10-03T13:32Z 106K followers, 364.5K engagements

"Recursion Rings Nasdaq Opening Bell Celebrating the Era of TechBio Executives from Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company visited the Nasdaq MarketSite in Times Square on January [--] to ring the Nasdaq Opening Bell and celebrate the Era of TechBio. The bell ringing comes on the heels of Recursions recent business combination with Exscientia which closed in November [----] bringing expanded partnerships and pipeline including both first-in-class and best-in-class programs across oncology and rare disease as well as other unmet needs. To mark the occasion co-founder and"
YouTube Link 2025-01-22T18:32Z [----] followers, [----] engagements

""Were focused on going places that we dont think other people can. On Sept. [--] Recursion cofounder and CEO Chris Gibson and Chief R&D Officer and Chief Commercial Officer Najat Khan presented at the Morgan Stanley 23rd Annual Global Healthcare Conference. They addressed macro concerns facing healthcare companies the evolution of the platform and integration of Boltz-2 pipeline strategy and what we anticipate from partnership milestones. 🔹 On rising competition from China. Chris: At Recursion our focus is on going places that are first-in-class or best-in-class in undruggable areas of biology"
YouTube Link 2025-09-16T13:28Z 106K followers, [----] engagements

"How Recursion Uses Imaging Data & Foundation Models to Understand Biology Imran Haque SVP of AI and Digital Sciences at Recursion discusses the massive advances that have been made in training foundation models to make predictions using cell imaging data. See the full video here: https://www.youtube.com/watchv=0r-Quvc3jno #ai #ml #tech #techbio #chemistry #biology #models"
YouTube Link 2024-09-06T19:00Z [----] followers, [---] engagements

"Behind Recursion's Transformational Partnership with Roche and Genentech In December [----] Recursion entered into a multi-year strategic collaboration with Roche and Genentech in key areas of neuroscience and an oncology indication. Through the partnership Recursion is working with both Roche and Genentech's R&D units to leverage the Recursion OS and Maps of Biology along with extensive single-cell perturbation screening data from Roche and Genentech to rapidly identify novel biological relationships to initiate and advance therapeutic programs"
YouTube Link 2022-09-14T22:48Z [----] followers, [----] engagements

"How Recursion Is Building a Virtual Cell to Supercharge Drug Discovery During the Q2 [----] (L)earnings Call Recursion cofounder and CEO Chris Gibson shared Recursions approach to building a virtual cell that can predict how cells will respond to different genetic or chemical changes and why it will require the integration of numerous data layers beyond really good protein folding data. It will include he said really good atomistic and physics modeling as well as patient and pathway data. Recursion is at the forefront of those layers Chris noted with access to extensive patient data via"
YouTube Link 2025-08-06T14:11Z 106K followers, [----] engagements

"How Recursion Is Collaborating with Bayer on the Next Generation of Cancer Treatments The Bayer - Recursion collaboration brings together Recursions technology-forward and AI-leading emphasis and Bayers legacy of drug development. The $1.5B deal announced last October in precision oncology already has one joint project now rapidly advancing to Lead Series nomination and we are on track to complete [--] unique multimodal data packages in Q3 [----]. Bayer will be the first beta-user of Recursion's LOWE LLM-orchestrated workflow software which will be integrated across the collaboration and offer a"
YouTube Link 2024-07-02T12:00Z [----] followers, [----] engagements

"The State of AI Drug Discovery & Recursion's Competitive Moat at BofA Health Care Conference Earlier this week Recursion Chief Financial Officer Ben Taylor and Chief Medical Officer David Mauro spoke at the Bank of America Securities [----] Health Care Conference with Senior Biotech Analyst Alec Stranahan. They discussed whether weve reached an inflection point for AI-designed drugs Recursions competitive moat and the evolution of the company. Key takeaways: Is there a ChatGPT moment for AI in healthcare Ben: What we will see is drugs repeatedly having some aspect of AI incorporated into their"
YouTube Link 2025-05-15T16:29Z 23.7K followers, [---] engagements

"David Mauro Chief Medical Officer Discusses Recursion's Pipeline Programs at Download Day Recursion's Chief Medical Officer David Mauro MD PhD presents on Clinical Programs at Download Day [----]. About Recursion: Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS) a platform built across diverse technologies that continuously expands one of the worlds largest proprietary biological chemical and patient-centric datasets. Recursion leverages sophisticated machine-learning algorithms"
YouTube Link 2024-06-28T12:22Z [----] followers, [---] engagements

"Recursion CEO's Opening Remarks at Nasdaq Opening Bell All the pieces are now in place. In his opening remarks at today's Nasdaq Opening Bell co-founder and CEO Chris Gibson shared why today is important not just for Recursion but for the larger TechBio industry. All the pieces are now in place the automated laboratories the incredible scaled compute the data. This is the beginning of the Era of TechBio. Watch the full video here: https://www.youtube.com/watchv=JX_24XZAKJg"
YouTube Link 2025-01-22T18:37Z [----] followers, [---] engagements

"Bold Bets Breakthroughs and Bottlenecks in AI Drug Discovery at BIO In June Recursion chief R&D officer and chief commercial officer Najat Khan PhD joined a panel of industry leaders at BIO in Boston including Stacie Calad-Thomson Karen Akinsanya Martha Head Derek Lowe and Gregg Talbert to discuss the tangible progress thats already been made leveraging data and AI approaches to drug discovery and her hopes for the next 5-10 years. 💡 A few highlights: 🔹 On how weve changed the speed and efficiency of novel drug discovery with data and AI. RMB39 is a program that went from target ID to"
YouTube Link 2025-07-24T13:54Z 106K followers, [---] engagements

"What Does the Industrialization of Drug Discovery Mean In this video Lina Nilsson PhD Chief Platform Officer shares what we mean by industrialization at Recursion. The video is part of our internal RXU learning platform which provides deep dives into our mindset mission and value drivers. 🔹 Industrialization Is an Entirely New Approach Industrialization of drug discovery isnt about improving processes by small increments Lina says but imagining an entirely new approach to the way medicines are created from start to finish i.e. not a better candle but a lightbulb. Not a taller ladder but an"
YouTube Link 2025-08-08T14:51Z 106K followers, [----] engagements

"Najat Khan PhD Gives Afternoon Convocation at Download Day Recursion's Chief R&D Officer and Chief Commercial Officer Najat Khan PhD presents at Download Day [----]. About Recursion: Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS) a platform built across diverse technologies that continuously expands one of the worlds largest proprietary biological chemical and patient-centric datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a"
YouTube Link 2024-06-28T12:22Z [----] followers, [----] engagements

"Optimizing Strategies for Clinical Development using Data and AI At the recent Reuters Pharma USA event in Philadelphia Hemanth Kanakamedala VP of Decision Science and Real World Evidence at Recursion spoke with Jonah Comstock of PharmaPhorum about optimizing strategies for clinical development using data and AI. 🔹 How the goalposts are changing on applying real world evidence. If you think of the history of real world evidence primarily it was leveraged in the post-approval setting to inform value demonstration and as a value proposition really talking about the unmet need of certain"
YouTube Link 2025-04-21T15:23Z [----] followers, [---] engagements

"Download Day [----] Full Day Recursions Download Day [----] is the companys second R&D Day. Sell-side equity research analysts institutional investors and investment bankers joined members of Recursions executive team and board of directors for an engaging in-person event at the companys headquarters in Salt Lake City Utah. The day consisted of presentations on Recursions technology science pipeline and partnerships. This is the full recording of that day on June 24th [----]. Agenda: 00:00:00 Welcome Ryan Kelly Chief Communications Officer Recursion 00:01:28 State of Recursion Chris Gibson"
YouTube Link 2024-06-28T12:22Z [----] followers, [----] engagements

"Watch Recursion Build the Largest Supercomputer in Pharma From zero to supercomputer. A couple months ago we announced BioHive-2 the 35th most powerful supercomputer in the world and the top supercomputer in the pharma industry. Our team along with a team from NVIDIA worked over the course of three intense weeks to bring BioHive-2 to life. Biohive-2 is four times faster than our original supercomputer BioHive-1 and allows us to perform multiple ambitious projects with shorter timeframes unlocking even more insights from our 50+ petabytes of proprietary data. With it we are able to train"
YouTube Link 2024-07-31T19:12Z [----] followers, [----] engagements

"Recursion's Machine Learning Breakthroughs at ICML Researchers from Valence Labs Recursions AI research engine had a great time sharing our machine learning breakthroughs at the International Conference on Machine Learning (ICML) last week in posters and presentations including: 🔹 The Phenom-2 foundation model paper our largest foundation model for cell microscopy data to date presented by Kian Kenyon-Dean and Jason Hartford (https://openreview.net/forumid=niywLsa54R) 🔹 A new framework to enhance transcriptomics by distilling knowledge from microscopy images paper presented by Ihab Bendidi"
YouTube Link 2025-07-21T13:02Z 106K followers, [----] engagements

"TechBio Talks Episode 2: Broad Institute's Anne Carpenter with Host Chris Gibson In the second episode of TechBio Talks host Chris Gibson talks to Anne Carpenter Institute Scientist and Imaging Platform Senior Director at the Broad Institute of MIT and Harvard a pioneer in image-based profiling who played a key role in Recursions origin story. Anne talks about her early discovery that phenomics-based profiling could be as powerful as mRNA profiling; how she decides what data to make by determining the problems she can solve well; how these tools can be deployed to produce safer chemicals; the"
YouTube Link 2025-10-01T21:25Z 106K followers, 30.6K engagements

"Najat Khan PhD: Why I Left Pharma for TechBio Few people understand the TechBio transformation of pharma like Najat Khan PhD. Here [--] days into her new role as Chief R&D and Chief Commercial Officer at Recursion having previously led the data science and AI team at J&J she sat down to talk about what motivates her why she made the leap from pharma to TechBio and why AI drug discovery and development is ready to deliver. #ai #techbio #pharma #drugdiscovery #career #data #compute #technology #future"
YouTube Link 2024-09-30T14:21Z [----] followers, [----] engagements

"TechBio Talks Episode 1: MIT's Regina Barzilay with Host Najat Khan In the first episode of TechBio Talks host Najat Khan talks to Regina Barzilay -- Distinguished Professor at Massachusetts Institute of Technology and AI faculty lead at MIT Jameel Clinic MacArthur Genius Grant recipient and member of the National Academies of Medicine and Engineering. Regina and Najat discuss everything from Reginas work on early cancer detection models to what sparked the collaboration behind Boltz-2 the first open-source AI model for highly accurate protein binding affinity predictions from MIT alongside"
YouTube Link 2025-09-03T20:26Z 106K followers, 34.9K engagements

"First Patient Dosed in Recursion's Phase 1/2 Clinical Study of REC-1245 📣 Announcing the first patient dosed in our Phase 1/2 clinical study of REC-1245. REC-1245 is a potential first-in-class RBM39 degrader for biomarker-enriched solid tumors and lymphoma and the first program to emerge from end-to-end use of the RecursionOS. We used our AI-powered Maps of Biology to both identify a novel target and new chemical matter and progressed REC-1245 from target ID to IND-enabling studies in under [--] months with [---] compounds synthesized much faster and more efficient than industry average. The"
YouTube Link 2024-12-03T14:13Z [----] followers, [---] engagements

"New AI Model from MIT & Recursion Predicts Protein Affinity for AI Drug Discovery 1000X Faster Boltz-2 is a new open source AI model from MIT and Recursion capable of predicting protein binding affinity with unprecedented speed scale and accuracy. Boltz-2 is the first model to combine structure and binding affinity prediction approaching the accuracy of physics-based free energy perturbation (FEP) calculations while being over [----] times faster and less computationally expensive. 💥 The model addresses a critical bottleneck in small molecule drug discovery. A powerful tool built on novel"
YouTube Link 2025-06-06T16:32Z [----] followers, [---] engagements

"Recursion CMO David Mauro and Deepak Nijhawan Discuss Phenotypic Discovery in Cancer at Download Day Recursion's Chief Medical Officer David Mauro MD PhD and Dr. Deepak Nijhawan MD PhD sit down for a Fireside Chat at Download Day [----]. About Recursion: Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS) a platform built across diverse technologies that continuously expands one of the worlds largest proprietary biological chemical and patient-centric datasets. Recursion leverages"
YouTube Link 2024-06-28T12:22Z [----] followers, [---] engagements

"Addressing the High Failure Rate in Drug Discovery Using Data and AI Last week at the AI x BIO Summit hosted by Decoding Bio and NYSE Recursion Chief R&D Officer and Chief Commercial Officer Najat Khan PhD spoke with BiotechTV about how were addressing three core drivers of the high failure rate in drug discovery using data and AI. Namely: Ensuring stronger efficacy predictions by leveraging data and AI to uncover deeper systems-level insights into disease biology. Ensuring safety and tolerability by using generative AI and active learning to design safer more drug-like molecules. Ensuring"
YouTube Link 2025-07-30T13:16Z 106K followers, 19.9K engagements

"How We're Leveraging AI to Address Key Pain Points in Drug Discovery -- Najat Khan PhD on Bloomberg Speaking to Bloomberg Radio Chief R&D and Chief Commercial Officer Najat Khan PhD shared how Recursion is directly addressing the pain points that lead to failures in the clinic through AI-enabled Maps of Biology. On Recursions AI-enabled approach. What Recursion is doing is leveraging AI and high-quality data that is generated in our own labs at scale to build AI algorithms that are used to really understand what is driving the disease. Then we use generative AI to design molecules that"
YouTube Link 2025-01-23T14:19Z [----] followers, [----] engagements

"Laura Schaevitz on Recursion's Preclinical Approach at Download Day Recursion's SVP and Head of Research Laura Schaevitz PhD presents on Recursion's Preclinical Approach and Programs at Download Day [----]. About Recursion: Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS) a platform built across diverse technologies that continuously expands one of the worlds largest proprietary biological chemical and patient-centric datasets. Recursion leverages sophisticated machine-learning"
YouTube Link 2024-06-28T12:22Z [----] followers, [----] engagements

"Recursion's ALDER Trial Recruitment Video Enrolling for Recursion's ALDER Trial for REC-3964"
YouTube Link 2025-01-27T20:10Z [----] followers, [--] engagements

"Regina Barzilay: Why AI Beats Humans for Early Cancer Detection In this clip from the first episode of our TechBio Talks podcast Regina Barzilay AI faculty lead at MIT Jameel Clinic tells host Najat Khan about one of the ways AI is having a meaningful impact on patients today detecting cancer earlier. Cancer involves a long process of tissue transformation she says and radiologists can generally only see evidence of cancer when the tumor is large enough after billions of cells have accumulated. AI tools like Reginas Mirai tool for breast cancer detection have been trained with millions of"
YouTube Link 2025-09-12T13:18Z 106K followers, [----] engagements

"Explore Recursions Mapping & Navigating Technologies - Imran Haque Senior VP AI & Digital Sciences Join Imran Haque Senior Vice President of AI & Digital Sciences for a walk-through example on how we apply our mapping and navigating technologies to explore both known and unknown areas of disease biology in an effort to discover new medicines. To learn more about our technology visit https://www.recursion.com/operating-system. About Recursion: Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the"
YouTube Link 2023-08-29T17:03Z [----] followers, [----] engagements

"Recursionauts Series: Tina Marriott Larson - Shaping the Future at Recursion Explore the fusion of science and technology with Tina Marriott Larson President and Chief Operating Officer at Recursion in our Recursionaut series. Tina brings her extensive experience in the biopharmaceutical industry to Recursion where she plays a pivotal role in advancing the future of drug discovery. 🔬 About Tina Marriott Larson: Tina's career spans engineering and leadership roles at Genentech Roche and Achaogen culminating in her leadership at Recursion. Recognized for her contributions to bioengineering and"
YouTube Link 2023-11-29T18:51Z [----] followers, [---] engagements

"Najat Khan PhD at Recursion's JPM Event: The Convergence of Biology ML & Supercomputing Is Here In her welcome remarks at Recursion's "Era of TechBio" event at the [----] J.P. Morgan Healthcare Conference Recursion Chief R&D and Chief Commercial Officer Najat Khan PhD shares why she is excited by the progress over the past year -- including [--] pipeline programs [--] advanced discovery programs and [--] active partnered programs"
YouTube Link 2025-02-11T21:15Z 18K followers, [---] engagements

"Recursion a timeline Recursion was founded in [----] and is celebrating its 10-year anniversary in [----]. In honor of [--] years of decoding #biology to radically improve lives we're reflecting on nearly a decade of work to industrialize #drugdiscovery by building maps of #biology and #chemistry that can help us navigate the path to new medicines more efficiently. #biotech #biopharma #ai #machinelearning #datascience Learn more at Recursion.com"
YouTube Link 2023-01-26T15:29Z [----] followers, [----] engagements

"Michael Secora PhD Presents on Company Milestones at Download Day Recursion's CFO Michael Secora PhD presents on the Company & Milestones at Download Day [----]. About Recursion: Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS) a platform built across diverse technologies that continuously expands one of the worlds largest proprietary biological chemical and patient-centric datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a"
YouTube Link 2024-06-28T12:22Z [----] followers, [---] engagements

"The Importance of Biology Imaging in the Age of AI: Anne Carpenter at MIT Recently Anne Carpenter a member of Recursions Scientific Advisory Board spoke at the Aging Brain Initiative at Massachusetts Institute of Technology (MIT) about the importance of biology imaging in the age of AI. The premise of her lab she said was to find a way to easily observe physical changes in cells that would indicate an underlying disease state. That led her to create a cell painting assay and cell profiling software that would allow for capturing and testing cell data at massive scale. If we can test cells at"
YouTube Link 2025-08-04T13:34Z 106K followers, [----] engagements

"Download Day [----] Preclinical Opportunities with Laura Schaevitz Recursion SVP & Head of Research Laura Schaevitz PhD Senior Vice President and Head of Research shares details on preclinical opportunities at Recursion at Download Day [----]. About Recursion: Recursion is a clinical-stage biotechnology company that aims to decode biology to radically improve lives. Recursion is harnessing the convergence of multiple breakthrough technologies that allow scientists to explore uncharted areas of biology and unravel its complexity to navigate the path to better treatments. The company has built a"
YouTube Link 2023-02-09T19:27Z [----] followers, [---] engagements

"Download Day [----] Recursion Co-Founder & Board Member Dean Li President of Merck Research Labs Dean Li MD PhD Co-founder and Board member at Recursion and President of Merck Research Labs presents an afternoon convocation at Recursion's Download Day [----]. About Recursion: Recursion is a clinical-stage biotechnology company that aims to decode biology to radically improve lives. Recursion is harnessing the convergence of multiple breakthrough technologies that allow scientists to explore uncharted areas of biology and unravel its complexity to navigate the path to better treatments. The"
YouTube Link 2023-02-09T19:26Z [----] followers, [----] engagements

"Recursion's Najat Khan: Patients Are Waiting In a clip from the latest installment in our internal RXU series where Recursion leaders reflect on our guiding principles and values Chief R&D Officer and Chief Commercial Officer Najat Khan talks about the importance of urgency. Najat grew up with physician parents her dad a trauma surgeon her mom a gynecologist turned radiologist and spent a lot of time in her early years at the hospital. She had several formative experiences where she witnessed the lives of young patients who couldnt be helped in time a 6-year-old girl rushed too late for an"
YouTube Link 2025-09-19T13:33Z 106K followers, [----] engagements

"Lina Nilsson Presents on the Recursion Operating System at Download Day Recursion's SVP of Inception Labs Lina Nilsson PhD presents on the Recursion Operating System (RecursionOS) at Download Day [----]. About Recursion: Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery. Central to its mission is the Recursion Operating System (OS) a platform built across diverse technologies that continuously expands one of the worlds largest proprietary biological chemical and patient-centric datasets. Recursion leverages sophisticated machine-learning"
YouTube Link 2024-06-28T12:22Z [----] followers, [----] engagements

"Using Machine Learning to Predict Patient Response to Treatment In this clip from the first episode of our podcast TechBio Talks Regina Barzilay AI faulty lead at MIT Jameel Clinic tells host Najat Khan how we can leverage machine learning to better predict how a patient will respond to treatments allowing us to improve his or her condition for the longest time with minimal side effects and then determine the best second line and third line treatment. These sorts of insights can both make a huge difference in somebodys life says Regina and also improve our understanding of resistance in"
YouTube Link 2025-09-23T13:25Z 106K followers, [---] engagements

"Recursion SLC Office Expansion & Showcase Unveiling Event We recently celebrated a few exciting milestones: our expansion into additional HQ space in #SLC the Recursion Foundation's incubator Altitude Lab joining us in the Gateway & the completion of our showcase collaboration with the Discovery Gateway Children's Museum and five murals by local artist Brooke Smart. About Recursion: Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS a platform built across diverse technologies that"
YouTube Link 2023-07-18T20:13Z [----] followers, [---] engagements

"The Role of High-Quality Data in AI Drug Discovery: Najat Khan PhD Recursion Chief R&D Officer and Chief Commercial Officer Najat Khan PhD speaks with Brendan Smith PhD from TD Securities for the first episode of Machine Medicine: AI & Health Care to discuss the role of high quality proprietary data and the latest advances in using AI in clinical trials patient stratification and predictive toxicology. A few takeaways: 🔹 When building an AI/ML model Najat says the first consideration needs to be around what questions you are trying to answer. With drug discovery that includes: Do we really"
YouTube Link 2025-05-14T13:10Z [----] followers, [---] engagements

"Recursion x NVIDIA event at JPM2024 Fireside Chat with Jensen Huang & Martin Chavez In response to the high demand following our event at #JPM24 (co-hosted with @NVIDIA) we're excited to share the full recording of the insightful #fireside chat between NVIDIA's Founder & CEO Jensen Huang and Recursion's Board Chair R. Martin Chavez. Their conversation touching on the intersections of #technology and #healthcare is representative of necessary collaboration across sectors to drive progress in #drugdiscovery and development in this new era of #AI. #compute #supercomputer #pharma #thoughtleaders"
YouTube Link 2024-02-05T18:31Z 30.3K followers, 53.1K engagements

"One Thing That Makes Me Excited to Come to Work at Recursion In this video Communications and Culture Fellow Katherine Matsumoto asks Recursionauts to share the one thing that most excites them about their work. #OneThing #culture #career"
YouTube Link 2025-10-16T13:37Z 106K followers, 582.7K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing